Clinical trials and biomarker development with molecularly targeted agents and radiotherapy

被引：0
|
作者：
Neesha Dhani
Lillian L. Siu
机构：
[1] University of Toronto,Princess Margaret Hospital, Division of Medical Oncology and Hematology, Department of Medicine
[2] Division of Medical Oncology and Hematology,Princess Margaret Hospital
来源：
Cancer and Metastasis Reviews | 2008年 / 27卷
关键词：
Clinical trials; Biomarker; Radiotherapy; Genomics; Prognosis; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：339 / 349
页数：10
相关论文
共 50 条
  • [41] Use of 'sham' radiotherapy in randomized clinical trials
    Schwarz, F.
    Christie, D.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2008, 52 (03) : 269 - 277
  • [42] Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation
    Batis, Nikolaos
    Brooks, Jill M.
    Payne, Karl
    Sharma, Neil
    Nankivell, Paul
    Mehanna, Hisham
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 176
  • [43] Nonalcoholic steatohepatitis (NASH) cirrhosis: a snapshot of therapeutic agents in clinical development and the optimal design for clinical trials
    Aggarwal, Pankaj
    Noureddin, Mazen
    Harrison, Stephen
    Jeannin, Sophie
    Alkhouri, Naim
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (02) : 163 - 172
  • [44] Targeted therapies and clinical trials in ovarian cancer
    Dancey, J.
    ANNALS OF ONCOLOGY, 2013, 24 : 59 - 63
  • [45] New targeted treatments in overview of clinical trials
    Korfee, S
    Gauler, T
    Hepp, R
    Pöttgen, C
    Eberhardt, W
    LUNG CANCER, 2004, 45 : S199 - S208
  • [46] Biomarker Research for Development of Molecular Target Agents
    Nishio, Kazuto
    Arao, Tokuzo
    NEW TRENDS IN THE MOLECULAR AND BIOLOGICAL BASIS FOR CLINICAL ONCOLOGY, 2009, : 29 - 36
  • [47] Investigating patient recruitment to radiotherapy clinical trials
    Thompson, Emma
    Clarkson, Melanie
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2016, 15 (03) : 232 - 238
  • [48] Immunosuppressive agents for Rheumatoid Arthritis: A systematic review of clinical trials and their current development stage
    Blaess, J.
    Walther, J.
    Petitdemange, A.
    Gottenberg, J. E.
    Sibilia, J.
    Arnaud, L.
    Felten, R.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 94 - 94
  • [49] Decade-Long Profile of Imaging Biomarker Use in Ophthalmic Clinical Trials
    Villani, Edoardo
    Massaro, Domenico
    Scaramuzzi, Matteo
    Hamrah, Pedram
    Medeiros, Felipe A.
    Nucci, Paolo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (06) : BIO76 - BIO81
  • [50] Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage
    Blaess, Julien
    Walther, Julia
    Petitdemange, Arthur
    Gottenberg, Jacques-Eric
    Sibilia, Jean
    Arnaud, Laurent
    Felten, Renaud
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2020, 12
12345